Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Hoth Therapeutics, Inc. HOTH

Set alert

Price alert · HOTH

All alert types
0.80 USD 0.00 0.00%

As of Aug 5, 3:59 PM ET

Bid
1.37 × 2
Ask
1.38 × 2
0.7911 Day range 0.835
0.58 52-week range 1.73
YTD
-19.06%
1 year
-43.57%
Open
0.82
Prev close
0.8013
Mkt cap
5.64M
Vol
40.06K
Avg vol
968.44K
EPS
-1.27
P/E
0.00
Div yield
0.00%
More statistics
Low
0.7911
High
0.835
Forward P/E
-1.15
Beta
0.00
Short ratio
0.25
Inst. own
5.31%
Dividend
0.00
Ex-div date
Earnings
Aug 9, 2024
50-d avg
0.85156
200-d avg
0.978545
1y target
4.50

3M chart

Chart tools
Interval
1m5m15m30m

Signals (21)
NameDateAgo
SMA: BullishMay 27, 20265 months ago
RSI: OverboughtMay 27, 20265 months ago
SMA: BullishMay 26, 20265 months ago
MACD: Buy SignalMay 22, 20265 months ago
MACD: Sell SignalMay 11, 20265 months ago
SMA: BearishMay 7, 20265 months ago
SMA: BullishMay 5, 20266 months ago
SMA: BearishMay 4, 20266 months ago
SMA: BullishApr 30, 20266 months ago
SMA: BearishApr 28, 20266 months ago
SMA: BullishApr 22, 20266 months ago
MACD: Buy SignalApr 15, 20266 months ago
RSI: OversoldApr 1, 20267 months ago
SMA: BearishMar 18, 20267 months ago
MACD: Sell SignalMar 18, 20267 months ago
MACD: Buy SignalMar 11, 20267 months ago
SMA: BullishMar 10, 20267 months ago
MACD: Sell SignalMar 10, 20267 months ago
SMA: BearishMar 6, 20268 months ago
SMA: BullishMar 4, 20268 months ago

Newest 20 of 21.

Financial health

Altman Z-Score

-10.68 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.1×
FY 2017: -40.7×FY 2018: -32.2×FY 2019: -7.4×FY 2020: -4.1×FY 2021: -1.0×FY 2022: -0.8×FY 2023: -0.6×FY 2024: -0.6×FY 2025: -1.1×
FY 2017 5y median -0.8× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 2.2×
FY 2017: 69.2×FY 2018: 519×FY 2019: 23.7×FY 2020: 6.3×FY 2021: 1.5×FY 2022: 1.8×FY 2023: 0.5×FY 2024: 0.7×FY 2025: 2.2×
FY 2017 5y median 1.5× FY 2025
P/FCF -1.4×
FY 2017: -107×FY 2018: -38.2×FY 2019: -11.3×FY 2020: -4.7×FY 2021: -1.2×FY 2022: -1.0×FY 2023: -0.6×FY 2024: -0.7×FY 2025: -1.4×
FY 2017 5y median -1.0× FY 2025
EV/EBITDA -0.6×
FY 2017: -40.1×FY 2018: -32.1×FY 2019: -7.1×FY 2020: -3.7×FY 2021: -0.4×FY 2022: -2941×FY 2023: -40.2×FY 2024: -82.5×FY 2025: -0.6×
FY 2017 5y median -40.2× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -71.7%
FY 2017: -0.9%FY 2018: -2.6%FY 2019: -8.9%FY 2020: -21.5%FY 2021: -82.8%FY 2022: -100.3%FY 2023: -172.1%FY 2024: -146.3%FY 2025: -71.7%
FY 2017 5y median -100.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -202.7%
FY 2017: -170.2%FY 2018: -1610.4%FY 2019: -321.1%FY 2020: -154.9%FY 2021: -144.8%FY 2022: -222.0%FY 2023: -82.3%FY 2024: -119.0%FY 2025: -202.7%
FY 2017 5y median -144.8% FY 2025
ROIC -180.5%
FY 2017: -158.0%FY 2018: -1610.4%FY 2019: -322.0%FY 2020: -148.1%FY 2021: -139.4%FY 2022: -206.0%FY 2023: -80.2%FY 2024: -118.9%FY 2025: -180.5%
FY 2017 5y median -139.4% FY 2025
ROA -164.0%
FY 2017: -163.3%FY 2018: -495.2%FY 2019: -271.3%FY 2020: -137.3%FY 2021: -130.3%FY 2022: -168.2%FY 2023: -76.6%FY 2024: -106.2%FY 2025: -164.0%
FY 2017 5y median -130.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -35.2%
FY 2017: 0.0%FY 2018: -33.3%FY 2019: -209.2%FY 2020: 5.4%FY 2021: -93.1%FY 2022: 21.5%FY 2023: 30.5%FY 2024: -6.8%FY 2025: -35.2%
FY 2017 FY 2025
EPS (diluted) 29.7%
FY 2017: 0.0%FY 2018: -26.3%FY 2019: -217.1%FY 2020: 30.6%FY 2021: -10.1%FY 2022: 40.7%FY 2023: 75.8%FY 2024: 44.3%FY 2025: 29.7%
FY 2017 FY 2025
Free Cash Flow -40.5%
FY 2017: 0.0%FY 2018: -173.5%FY 2019: -139.8%FY 2020: -25.0%FY 2021: -93.7%FY 2022: 23.2%FY 2023: 9.9%FY 2024: 17.4%FY 2025: -40.5%
FY 2017 FY 2025

Financial Health

Current Ratio 4.7×
FY 2017: 24.9×FY 2018: 1.4×FY 2019: 6.0×FY 2020: 15.3×FY 2021: 12.2×FY 2022: 4.8×FY 2023: 15.0×FY 2024: 9.2×FY 2025: 4.7×
FY 2017 5y median 9.2× FY 2025
Quick Ratio 4.7×
FY 2017: 24.9×FY 2018: 1.4×FY 2019: 6.0×FY 2020: 15.3×FY 2021: 12.2×FY 2022: 4.8×FY 2023: 15.0×FY 2024: 9.2×FY 2025: 4.7×
FY 2017 5y median 9.2× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2017: 0.6×FY 2018: 0.1×FY 2019: 0.2×FY 2020: 0.4×FY 2021: 0.6×FY 2022: 6494×FY 2023: -85.9×FY 2024: -258×FY 2025: 0.5×
FY 2017 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -36.2×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31